Lanthanum carbonate versus placebo for management of hyperphosphatemia in patients undergoing peritoneal dialysis: a subgroup analysis of a phase 2 randomized controlled study of dialysis patients

被引:0
作者
Alastair J Hutchison
Maggie Gill
J Brian Copley
Lynne Poole
Rosamund J Wilson
机构
[1] Manchester Royal Infirmary,Manchester Institute of Nephrology and Transplantation
[2] University of Manchester,Shire Pharmaceuticals
[3] Hampshire International Business Park,Spica Consultants
[4] Shire Pharmaceuticals,undefined
[5] Granary House,undefined
[6] Granary Close,undefined
来源
BMC Nephrology | / 14卷
关键词
Chronic kidney disease; Lanthanum carbonate; Nutrition; Peritoneal dialysis; Phosphate control;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 123 条
[41]  
Kaul A(undefined)undefined undefined undefined undefined-undefined
[42]  
Bhaduria D(undefined)undefined undefined undefined undefined-undefined
[43]  
Gupta A(undefined)undefined undefined undefined undefined-undefined
[44]  
Bergström J(undefined)undefined undefined undefined undefined-undefined
[45]  
Fürst P(undefined)undefined undefined undefined undefined-undefined
[46]  
Alvestrand A(undefined)undefined undefined undefined undefined-undefined
[47]  
Lindholm B(undefined)undefined undefined undefined undefined-undefined
[48]  
Boaz M(undefined)undefined undefined undefined undefined-undefined
[49]  
Smetana S(undefined)undefined undefined undefined undefined-undefined
[50]  
Gallieni M(undefined)undefined undefined undefined undefined-undefined